Products
At the heart of our offer... CPR Invest Biodiversity
Very early on, CPRAM chose to be an active player in environmental issues, building this expertise through a long process of integrating extra-financial criteria, progressively enriched with the rise of sustainability objectives within financial institutions and companies. Today, this strategy is reflected in a range of funds with €7.4 billion1 in assets under management, covering the main asset classes and catering to different risk profiles. Rodolphe Taquet highlights the challenges related to biodiversity loss and provides more details on the contribution of the CPR Invest – Biodiversity fund to reducing pressures on biodiversity.
Published on 12 November 2025
Why is biodiversity essential?
Biodiversity is an essential wealth for all life on Earth, providing vital elements such as oxygen, food, medicines, and raw materials. It also offers irreplaceable services like plant pollination, soil fertilization, and contributes to flood prevention... However, today, as we know, biodiversity is in danger, threatened by land use change, pollution, overexploitation of natural resources, and climate change. Its preservation should be a major concern for everyone because while nature does not need us, we need it.
Why is biodiversity protection a priority for the financial sector?
Preserving biodiversity is also an economic issue, as half of the global GDP depends on services provided free of charge by biodiversity! If nothing is done, no less than 500 billion dollars per year2 will need to be allocated worldwide to stop its loss.
Recently, a scientific report3 estimated the unaccounted costs of damage caused by industrial activities to nature at an annual amount between 10,000 and 25,000 billion dollars, equivalent to a quarter of the global GDP. On the international level, this issue has only recently begun to be taken into account.
Thus, the Kunming-Montreal Agreement, which we consider the most important framework for biodiversity protection, was only established in 2022 during COP 15 in Montreal. This agreement is to biodiversity preservation what the Paris Agreement is to the fight against climate change. Signed by nearly 200 states, it sets the clear goal of protecting 30% of the planet by 2030 and also offers a toolbox of 23 targets aimed at enabling the implementation of concrete actions.
In what way is CPRAM legitimate to address issues related to biodiversity?
At CPRAM, we are convinced that financial actors can and must play a decisive role in the transition to a sustainable economy. It is this conviction that led us to create our first climate strategy as early as 2018. Since then, this offering has expanded with numerous solutions covering the main asset classes and different risk profiles, managing assets totaling €7.4 billion1.
Today, we are broadening our scope to include biodiversity preservation by building on this expertise.
Like climate, biodiversity protection requires the ability to analyze and examine companies' activities or practices and to understand the actions they have implemented to reduce their impact.
Our strength on these issues lies in our ability to structure and deploy a rigorous methodology based on efficient internal analytical tools capable of covering multiple metrics.
How can CPR Invest – Biodiversity support companies on biodiversity?
First and foremost, we wanted our solution to align with formal frameworks, namely: the Kunming-Montreal Biodiversity Agreement, the Paris Agreement on climate, as well as several Sustainable Development Goals.
This biodiversity strategy is also the result of a scientific approach conducted in collaboration with the National Museum of Natural History and teams from CPRAM4: research, management, strategy, analysts...
Finally, rather than exclusively targeting actors developing "turnkey niche solutions" addressing biodiversity challenges, we chose to support the transformation of companies.
How does this translate at the fund level?
CPR Invest Biodiversity is a 100% international equity fund actively managed that invests in companies worldwide and across all sectors, excluding fossil energy, to support the transition towards better practices in favor of biodiversity. Its investment process is built on a proprietary methodology that allows us to analyze companies by taking into account several key steps:
- We exclude companies with a negative environmental impact or controversial practices (for example: pesticides, palm oil, deforestation, etc.).
- We allocate a significant weight within our portfolio to sectors with a strong impact on biodiversity, as their efforts will have the greatest environmental impact.
- We select the companies most committed to biodiversity preservation according to a methodology built on three pillars: land, water, and climate, which evaluates the companies' transition. Investment within the portfolio naturally respects both financial objectives (profitability criteria, sectoral or geographical deviation from the index, etc.) and extra-financial criteria (ESG, biodiversity).
- We engage companies to raise awareness of the issues and improve their environmental practices. As this is a listed equity fund, our engagement policy is expressed both through dialogue with companies and active voting at general meetings.
- We communicate the concrete results of our approach and raise awareness among stakeholders. Our experts participate in the essential educational effort, both with institutional investors and final investors.
Finally, our fund commits to improving three indicators compared to its benchmark index, one per pillar of the methodology: a better waste recycling rate, reduced water consumption, and lower carbon intensity. CPR Invest - Biodiversity is a portfolio of approximately 90 stocks resulting from an integrated approach where financial and extra-financial choices mutually enrich each other.
1. CPRAM source as of June 30, 2025
2. WWF, in partnership with the Global Trade Analysis Project, Global Futures Report, 2020
3. World Bank, Preserving biodiversity to preserve our future, 12/2022
4. The expertise provided by the MNHN and its experts does not in any way concern the investment process, portfolio construction, and/or the selection of securities for the Fund. CPRAM remains solely responsible for the choice and implementation of this strategy. All trademarks and logos used above for informational purposes are the property of their respective owners.
Warning
Statements collected on 11/10/2025. Comments, estimates, viewpoints, analyses, and projections on markets and their developments reflect the opinion of CPRAM as of the publication date and do not engage the company's liability. The information provided has no contractual value and does not constitute investment advice or recommendations to buy or sell. They are based on sources considered reliable by CPRAM, which does not guarantee their accuracy, relevance, or completeness. This publication may not be reproduced, in whole or in part, or communicated to third parties without prior authorization from CPRAM. Subject to compliance with its obligations, CPRAM cannot be held responsible for financial or any other consequences resulting from the investment.
For more details on risks, investment policy, costs, ancillary fees, and other expenses, please refer to the Prospectus and the PRIIPs KID.
The fund is primarily exposed to the risk of capital loss, sought overexposure risk, credit risk, currency risk, interest rate and market risk, inflation decrease/increase risk, arbitrage risk, risk related to investments in emerging countries, volatility risk, liquidity risk, counterparty risk, liquidity risk related to temporary sales and acquisitions of securities and/or total return swap (TRS) contracts, and discretionary risk.
Nothing guarantees that the professionals currently employed by CPRAM will continue to be employed or that the past performance or success of an employee serves as an indicator of their future performance or success.